Ahmad Almaya is Director of Global Regulatory Affairs at Lilly, where he is responsible for CMC regulatory activities supporting global regulatory submissions for Lilly synthetic molecule development projects and commercial products from US manufacturing sites. Ahmad received his B.S. in Pharmacy from The University of Jordan, Ph.D. in Pharmaceutics from
The University of Iowa, and an Executive Certificate in the Business of Life Sciences from Kelley School of Business, Indiana University.
Read More